Clinical Trial Update: Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial of GX-H9 in pediatric growth hormone deficiency has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• GX-H9 (GX-H9)

Snippet

Sponsor: Genexine, Inc. | Conditions: Growth Hormone Deficiency | Phase 2 | Status: COMPLETED